Estrogen and Progesterone Receptors Expression in Uterine Malignant Smooth Muscle Tumors: Correlation with Clinical Outcome

REFERENCES

• Silverberg SG. Leiomyosarcoma of the uterus. A clinico-pathologic study. Obstet Gynecol 1971; 38: 613–628.
   Web of Science ®Google Scholar
• Wilkinson N, Rollason TP. Recent advances in the pathology of smooth muscle tumours of the uterus. Histopathology. 2001; 39: 331–341.
   PubMed Web of Science ®Google Scholar
• Clement PB. The pathology of uterine smooth muscle tumors and mixed endometrial stroma-smooth muscle tumors: a selective review with emphasis on recent advances. Int J Gynecol Pathol 2000; 19: 39–55.
   PubMed Web of Science ®Google Scholar
• Evans HL, Chawla SP, Simpson C, Finn KP. Smooth muscle neoplasms of the uterus other than ordinary leiomy-oma. A study of 46 cases, with emphasis on diagnostic crite-ria and prognostic factors. Cancer 1988; 62: 2239–2247.
   Google Scholar
• Kempson RL, Hendricks. Pure mesenchymal neoplasm of the uterine corpus. In: H. Fox, ed. Haines and Taylor obstetrical and gynaecological pathology. 3rd ed. Edinburgh: Churchill Livingstone, 1987: 411-456.
   Google Scholar
• Zaloudek CJ, Norris HJ. Mesenchymal tumors of the uterus. In: RJ Kurman (ed.) Blausteins' pathology of the female genital tract (3th ed.), Springer, New York 1987: 373-408.
   Google Scholar
• Nola M, Babic D, Ilic J, et al. Prognostic parameters for survival of patients with malignant mesenchymal tumors of the uterus. Cancer 1996; 78: 2543–2550.
   PubMed Web of Science ®Google Scholar
• Chang LK, Crabtree GS, Lim-Tan SK, et al. Primary uterine endometrial stromal neoplasms. A clinicopathologic study of 117 cases. Am J Surg Pathol 1990; 14: 415–438.
   PubMed Web of Science ®Google Scholar
• Silverberg SG. Reproducibility of the mitosis count in the histologic of smooth muscle tumours of the uterus. Hum Pathol 1976; 7: 451–454.
   PubMed Web of Science ®Google Scholar
• Major FJ, Blessing JA, Silverberg SG et al. Prognostic factors in early stage uterine sarcoma. Cancer 1993; 71: 1702–1709.
   Google Scholar
• Silverberg SG. Reproducibility of the mitosis count in the histologic of smooth muscle tumours of the uterus. Hum Pathol. 1976; 7: 451–454.
   PubMed Web of Science ®Google Scholar
• Ellis PSJ, Whitehead R. Mitosis counting: a need for reappraisal. Hum Pathol. 1981; 12: 3–4.
   PubMed Web of Science ®Google Scholar
• Jeffers MD, Oakes SJ, Richmond JA, Macaulay EM. Proliferation, ploidy and prognosis in uterine smooth muscle tumours. Histopathology. 1996; 29: 217–223.
   PubMed Web of Science ®Google Scholar
• Bell SW, Kempson RL, Hendrickson MR. Problematic uterine smooth muscle neoplasms. Am J Surg Pathol. 1994; 18: 535–558.
   PubMed Web of Science ®Google Scholar
• Jones MW, Norris HJ. Clinicopathologic study of 28 uterine leiomyosarcomas with metastasis. Int J Gynecol Pathol. 1995; 14: 243–249.
   PubMed Web of Science ®Google Scholar
• Zaloudek C, Norris HJ. Mesenchymal tumors of the uterus. In Kurman RJ, editor. Blaustein's pathology of the female genital tract. 4th edition. New York: Springer-Verlag, 1994: 487-528.
   Google Scholar
• Ali S, Wells M. Mixed mullerian tumors of the uterine corpus: a review. Int J Gynecol Cancer. 1993; 3: 1–11.
   PubMed Web of Science ®Google Scholar
• Major FJ, Blessing JA, Silverberg SG et al. Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study. Cancer. 1993; 71: 1702–1709.
   Google Scholar
• Nola M, Babic D, Ilic J, et al. Prognostic parameters for survival of patients with malignant mesenchymal tumors of the uterus. Cancer 1996; 78: 2543–2550.
   PubMed Web of Science ®Google Scholar
• Mayerhofer K, Obermairn A, Windbichler G, Petru E, Kaiser A, Hefler L et al. Leiomyosarcoma of the uterus: a din-icopathologic multicenter study of 71 cases. Gynecol Oncol. 1999; 74: 196–201.
   Google Scholar
• Kurman RJ. Blaustein's pathology of the female genital tract. 5th ed./editor, Robert J Kurmann. Spriner-Verlag New York Berlin Heidelberg.
   Google Scholar
• TNM Classification of malignant tumours. UICC. Sobin LH and Wittekind Ch Editors. Geneva, Switzerland. Sixty ed. 2002.
   Google Scholar
• Mayerhofer K, Obermairn A, Windbichler G, Petru E, Kaiser A, Hefler L et al. Leiomyosarcoma of the uterus: a din-icopathologic multicenter study of 71 cases. Gynecol Oncol. 1999; 74: 196–201.
   Google Scholar
• Li B, Shiozawa T, Nakayama K, Nikaido T, Fujii S. Stepwise abnormality of sex steroid hormone receptors, tumor suppressor gene products (p53 and Rb), and Cyclin E in uter-ine endometrioid carcinoma. Cancer. 1996; 77: 321-327.
   Google Scholar
• Zhai YA, Kobayashi Y, Mori A, Orii A, Nikaido T, Konishi I, Fujii S. Expression of steroid receptors, Ki-67, and p53 in uterine leiomyosarcomas. Int J Gynecol Pathol. 1999; 18: 20–28.
   PubMed Web of Science ®Google Scholar
• Bodner K, Bodner-Adler B, Kimberger O, Czerwenka K, Leodolter S, Mayerhofer K. Estrogen and Progesterone receptor expression in patients with uterine leiomyosarcoma and correlation with different clinicopathological parameters. Anticancer Res. 2003; 23: 729–732.
   PubMed Web of Science ®Google Scholar
• Stata Press: Statistics- Stata 7. Reference Q-ST. 4905 Lakeway Drive, College Station, Texas 77845, 2000.
   Google Scholar
• Kaplan EL, Meier P. Nonparametric estimationfrom incomplete observations. J Am Stat Assoc. 1958; 53: 457–481.
   Web of Science ®Google Scholar
• Osborne CK, Yochmowitz MG, Knight WA et al. The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer. 1980: 46: 2884–2888.
   Google Scholar
• Enrlich CE, Young PCM, Cleary RE. Cytoplasmatic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: therapeutic implications Am J Obstet Gynecol. 1981; 141: 539–546.
   Google Scholar
• Brandis A, Mirzai S, Tabagiba M, Walter GF, Samii M, Ostertag H. Immunohistochemical detection of female sex ormone receptor in meningiomas: correlation with clinical and histological features. Neurosurgery. 1993; 33: 212–218.
   PubMed Web of Science ®Google Scholar
• Kawaguchi K, Fujii S, Konishi I et al. immunohisto-chemical analysis of oestrogen receptors, progesterone recep-tors and Ki-67 in leiomyoma and myometrium during the menstrual cycle and pregnancy. Vircow Arch A Pathol Anat 1991; 419: 309–315.
   Google Scholar
• Brandon DD, Bethea CL, Strawn EY, et al. Progesterone receptors messenger ribonucleic acid and pro-tein are overexpressed in human uterine leiomyomas. Am J Obstet Gynecol. 1993; 169: 78–85.
   PubMed Web of Science ®Google Scholar
• Zhai YA, Kobayashi Y, Mori A, Orii A, Nikaido T, Konishi I, Fujii S. Expression of steroid receptors, Ki-67, and p53 in uterine leiomyosarcomas. Int J Gynecol Pathol 1999; 18: 20–28.
   PubMed Web of Science ®Google Scholar
• Kanetoshi K, Shingo F, Ikuo K et al. Immunohistochemical analysis of estrogen receptors, proges-terone receptors and Ki-67 in leiomyoma and myometrium during the menstrual cycle and pregnancy. Virchow Archiv A Pathol Anat 1991. 419: 309–315.
   Google Scholar
• Filicori M, Hall DA, Loughlin J et al. A conservative approach to the management of uterine leiomyomata: pitu-itary desensitisation by luteinising hormone releasing hormone analogue. Am J Obstet Gynecol 1983; 147: 726–727.
   Google Scholar
• West CP, Lumsden MA, Lawson S, Williamson J, Baird DT. Shrinkage of uterine fibroids during therapy with Zoladex (ICI 118630): a luteinising hormone releasing hormone ago-nist administered as a monthly subcutaneous depot. Fertil Steril 1987; 48: 45–51.
   PubMed Web of Science ®Google Scholar
• Tiltman AJ. The effect of progestins on the mitotic activity of uterine fibromyomas. I J Gynecol Pathol 1985; 4: 89–96.
   PubMed Web of Science ®Google Scholar
• Wu X, Blanck A, Olovsson M, Moller B, Favini R, Lindblom B. Apoptosis, cellular proliferation and expression of p53 in human uterine leiomyomas and myometrium during the menstrual cycle and after menopause. Acta Obstet Gynecol Scand 2000; 79: 397–404.
   PubMed Web of Science ®Google Scholar
• Soper JT, McCarty KS, Hinshaw W et al. Citoplasmic estrogen and progesterone receptor content of uterine sarco-mas. Am J Obstet Gynecol 1984; 150: 342–348.
   Google Scholar
• Sutton GP, Stehman FB, Michael H et al. Estrogen and progesterone receptors in uterine sarcomas. Obstet Gynecol 1986; 68: 709–714.
   PubMed Web of Science ®Google Scholar
• Mittal K, Demopoulos RI. MIB1 (Ki-67), p53, estrogen, and progesterone receptor expression in uterine smooth mus-cle tumors. Hum Pathol. 2001; 32: 984–987.
   PubMed Web of Science ®Google Scholar
• Thai Y-L, Kobayashi Y, Mori A et al. Expression of steroid receptors, Ki-67, and p53 in uterine leiomyosarcomas. Int J Gynecol Pathol. 1999; 18: 20–28.
   PubMed Web of Science ®Google Scholar